IDO1 and neoplasm: The upregulation of immunosuppression-associated molecules, such as programmed cell death protein 1(PD1) and indoleamine 2,3-dioxygenase (IDO) in tumor cells, significantly impairs the immune system’s ability to recognize and attack cancer cells.